DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Sanofi News

Apogee Therapeutics Reports 71% EASI Reduction in 16-Week Phase 2 Trial; KalVista Gains FDA Approval for EKTERLY Oral HAE Drug

Apogee Therapeutics Reports 71% EASI Reduction in 16-Week Phase 2 Trial; KalVista Gains FDA Approval for EKTERLY Oral HAE Drug

20

27 days ago

FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma After ≥4 Therapies; EU Approves GSK’s Blenrep, Sanofi’s Sarclisa, and CHMP Backs Multiple Treatments

FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma After ≥4 Therapies; EU Approves GSK’s Blenrep, Sanofi’s Sarclisa, and CHMP Backs Multiple Treatments

7

9 days ago

Latest stories